chartexchange

SYRS
SYROS PHARMACEUTICALS INC
stockOTC

EODNov 18, 2026
0.0001USD0.000%(0.00)9,653
Loading…
Loading…
Healthcare
Biotechnology
CEO
Nancy Simonian
HQ
Cambridge, MA, USA
Previous Close
$0.00
Beta
-28.32
52-Week High
$0.01 2026-09-17
52-Week Low
$0.00 2026-07-27
SMA 50
$0.00
SMA 200
$0.00
Avg. Vol 10D
6,862
Avg. Vol 30D
9,373
Avg. Vol 90D
10,954
Relative Vol
1.03
26.83M
Sep 19, 2022 · 1-for-10 (reverse)
SYRS Profile

syros pharmaceuticals is a life sciences company that is focused on treating disease by mapping gene regulatory circuits and modulating the factors that regulate gene expression. syros has pioneered world-leading gene control research and drug discovery capabilities with a proven ability to integrate disease biology and genomic data--a proficiency that is not well represented in pharmaceutical r&d. central to the syros approach is a proprietary platform of carefully integrated assay technologies, bioinformatics, and biologic insights developed by members of syros' senior leadership. while this scientific approach has applications in many therapeutic areas, syros has demonstrated success initially in oncology, where it may help address numerous unmet medical needs.

SYRS Performance
PeriodPriceDateChangeBeta
1M0.002026-10-19-75.00%0.219
3M0.002026-08-19-75.00%0.810
6M0.002026-05-19-50.00%-11.062
1Y0.002025-11-19-84.61%-28.323
2Y0.282024-11-19-99.96%—
5Y38.802021-11-19-100.00%-12.715
SYRS Stock Summary

SYROS PHARMACEUTICALS INC (OTC:SYRS) stock price today is $0.00, and today's volume is 9,653. SYRS is up 0.000% today. The 30 day average volume is 9,373. SYRS market cap is $2,683 with 26.83M shares outstanding.